EN
抗体药类似物
Research Grade Sirukumab
All
TD-HY328036_1.jpg
TD-HY328036_2.jpg
  • CatalogTD-HY328036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsCNTO 136, CAS: 1194585-53-9
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Sirukumab


Catalog No. TD-HY328036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-kappa
Expression system Mammalian Cells
Species Human
Clonality Monoclonal
Target Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession P05231
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternate Names CNTO 136, CAS: 1194585-53-9
Background Sirukumab (CNTO-136) is a humanized monoclonal anti-IL6 (Interleukin Related) IgG1κ antibody. Sirukumab binds to IL6, preventing IL6-mediated signal transduction and activation of transcriptional activators, thereby blocking the downstream biological effects of IL6. Sirukumab can be used in the study of active lupus nephritis and rheumatoid arthritis.
Note For research use only. Not suitable for clinical or therapeutic use.

 

TD-HY328036_1.jpg
Bioactivity
 
Detects IL6 in indirect ELISAs.
TD-HY328036_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Sirukumab.